Precision Scientific
Beijing · Founded 2015
About Precision Scientific
Precision Scientific provides drug mechanism research services for pharmaceutical and biotechnology companies. The company's self-developed cutting-edge AI technology ALBERT (AI-driven Big data analytics for Effective Response of cancer Therapy) is a machine learning-based analysis of multi-omics data using data mining and predictive algorithms to provide solutions for oncology research, including drug target discovery, biomarker identification, indication selection, drug resistance mechanism evaluation, and combo therapy strategy.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $28.0M
- Last round: Series Unknown (Dec 2025)
- Website: https://www.precisionscientific.com
- Phone: 400-967-0696
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Market Research, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/precision-scientific-44427 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.